New hope for advanced cancers: SNV1521 enters human trials
Disease control
Recruiting now
This early-stage study tests a new medicine called SNV1521 in people with advanced solid tumors that have spread or cannot be removed. The main goals are to check if the drug is safe, tolerable, and to find the best dose. About 400 participants will receive different doses, and s…
Phase: PHASE1 • Sponsor: Synnovation Therapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:49 UTC